These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 20651984
1. Calcium channel blocker verapamil enhances endoplasmic reticulum stress and cell death induced by proteasome inhibition in myeloma cells. Meister S, Frey B, Lang VR, Gaipl US, Schett G, Schlötzer-Schrehardt U, Voll RE. Neoplasia; 2010 Jul; 12(7):550-61. PubMed ID: 20651984 [Abstract] [Full Text] [Related]
2. Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome, autophagy-lysosome and ER stress. Kawaguchi T, Miyazawa K, Moriya S, Ohtomo T, Che XF, Naito M, Itoh M, Tomoda A. Int J Oncol; 2011 Mar; 38(3):643-54. PubMed ID: 21174067 [Abstract] [Full Text] [Related]
8. The proteasome inhibitor CEP-18770 enhances the anti-myeloma activity of bortezomib and melphalan. Sanchez E, Li M, Steinberg JA, Wang C, Shen J, Bonavida B, Li ZW, Chen H, Berenson JR. Br J Haematol; 2010 Feb 01; 148(4):569-81. PubMed ID: 19958357 [Abstract] [Full Text] [Related]
15. Synergistic induction of apoptosis in multiple myeloma cells by bortezomib and hypoxia-activated prodrug TH-302, in vivo and in vitro. Hu J, Van Valckenborgh E, Xu D, Menu E, De Raeve H, De Bruyne E, Xu S, Van Camp B, Handisides D, Hart CP, Vanderkerken K. Mol Cancer Ther; 2013 Sep 01; 12(9):1763-73. PubMed ID: 23832122 [Abstract] [Full Text] [Related]
17. In vitro and in vivo selective antitumor activity of a novel orally bioavailable proteasome inhibitor MLN9708 against multiple myeloma cells. Chauhan D, Tian Z, Zhou B, Kuhn D, Orlowski R, Raje N, Richardson P, Anderson KC. Clin Cancer Res; 2011 Aug 15; 17(16):5311-21. PubMed ID: 21724551 [Abstract] [Full Text] [Related]